Stephen Honig practices a broad spectrum of business law, with emphasis on corporate, governance, mergers and acquisitions, securities laws and business planning. He is a member of the firm’s Corporate, Life Sciences and Biotechnology, and Private Equity practice groups.
Mr. Honig’s career has reflected the technological orientation of the New England area. Today, many of his engagements are in the life sciences, health care and social media. He also works with founders and senior executives in wealth planning and the interface between their corporate and personal lives.
Based on his experience over time in private and public company transactions, Mr. Honig attempts to apply practical approaches to an engagement, minimizing unnecessary costs and time in protracted negotiations and drafting where there is little client value added.
Industry sectors served include (in the life sciences) device manufacture, bio pharma and medical data and, additionally, social apps, photo-voltaics, electronics, computer hardware and software, semi-conductors, circuit boards, SaaS, telecom and e-commerce.
Mr. Honig has served as president of an SEC-registered investment advisor, represented companies and underwriters in public offerings and private placements, represented broker-dealers and market makers, and effected the entry of banks into the securities business.
Mr. Honig has served as trustee of family trusts and, in that capacity, has evaluated and supervised the investment of assets on behalf of the families. He also represents individual, institutional and venture capital investors in equity, debt and lease financings.
In March 2011, Mr. Honig taught American business law and entrepreneurship at the University of Belgorod in southwestern Russia. Mr. Honig has taught securities law and regularly lectures and writes on governance issues, shareholder disputes, cyber risk, securities law regulation, Sarbanes-Oxley, Dodd-Frank and the representation of senior executives in establishing compensation regimes in both public and private companies.
- Representing social application startup in company formation, international taxation and intellectual property matters.
- Sale of medical device company out of chapter 11 in sealed bid auction process with various IP-sensitive bidders.
- Effected merger of life sciences research company with broker/dealer registered investment banking firm.
- Assisted investors in multi-tiered biotech company in structuring an exit format satisfactory to investors, common stockholders and management.
- Representing offshore strategic investor in bridge financing of VC-backed Silicon Valley technology company.
- Resurrection of publicly registered company after ten year dormancy, with related SEC clearances.
- Structured and implemented international licensing regime for American-based, Harvard-affiliated business consulting concern.
- Represented senior executive employee in connection with whistleblower/Sarbanes-Oxley investigation.
- Served as an expert witness in cases involving the standard of care for corporate representation in emerging companies.
- Representation of bank in negotiating of master custodial agreements and related securities transaction documentation.
- Harvard Law School, LL.B., 1966
- Columbia College, A.B., 1963
- U.S. Court of Appeals for the First Circuit
- U.S. District Court for the District of Massachusetts
- Supreme Court of Massachusetts
- Schnader Harrison Goldstein & Manello, Boston, Massachusetts, – Partner, 2000-2002
- Goldstein & Manello P.C., Boston, Massachusetts, – Founding Partner, 1976-1999
- Widett & Widett, Boston, Massachusetts, – Partner, 1971-1976
- Duane Morris LLP, – Partner, 2003-present
- Massachusetts Bar Association,
- Securities Law Committee
- Boston Bar Association,
- Securities Law Committee
- National Association of Corporate Directors
- Chair, Programming/New England Chapter, 2006-2008
- Member of Board of Directors, 2008-2014
- Member, New England Advisory Council, 2014-present
- Member, Massachusetts Medical Device Industry Council
- Mentor, Mass Challenge, a mentoring consortium for emerging businesses
Rate : $$$$